These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
543 related articles for article (PubMed ID: 24007214)
1. Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma. Que R; Ding G; Chen J; Cao L World J Surg Oncol; 2013 Sep; 11():219. PubMed ID: 24007214 [TBL] [Abstract][Full Text] [Related]
2. Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor. Warnecke-Eberz U; Chon SH; Hölscher AH; Drebber U; Bollschweiler E Tumour Biol; 2015 Jun; 36(6):4643-53. PubMed ID: 25631748 [TBL] [Abstract][Full Text] [Related]
3. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis. Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239 [TBL] [Abstract][Full Text] [Related]
4. Role of exosomal microRNA-125b-5p in conferring the metastatic phenotype among pancreatic cancer cells with different potential of metastasis. Wu M; Tan X; Liu P; Yang Y; Huang Y; Liu X; Meng X; Yu B; Wu Y; Jin H Life Sci; 2020 Aug; 255():117857. PubMed ID: 32470446 [TBL] [Abstract][Full Text] [Related]
5. A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer. Lai X; Wang M; McElyea SD; Sherman S; House M; Korc M Cancer Lett; 2017 May; 393():86-93. PubMed ID: 28232049 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing. Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918 [No Abstract] [Full Text] [Related]
7. Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer. Hua Y; Chen H; Wang L; Wang F; Wang P; Ning Z; Li Y; Liu L; Chen Z; Meng Z Cancer Biomark; 2017 Jul; 20(1):95-100. PubMed ID: 28759959 [TBL] [Abstract][Full Text] [Related]
8. Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Takeshita N; Hoshino I; Mori M; Akutsu Y; Hanari N; Yoneyama Y; Ikeda N; Isozaki Y; Maruyama T; Akanuma N; Komatsu A; Jitsukawa M; Matsubara H Br J Cancer; 2013 Feb; 108(3):644-52. PubMed ID: 23361059 [TBL] [Abstract][Full Text] [Related]
9. Exosomal miRNAs as circulating biomarkers for prediction of development of haematogenous metastasis after surgery for stage II/III gastric cancer. Liu X; Chu KM J Cell Mol Med; 2020 Jun; 24(11):6220-6232. PubMed ID: 32383554 [TBL] [Abstract][Full Text] [Related]
10. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer. Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients. Sun B; Liu X; Gao Y; Li L; Dong Z Br J Biomed Sci; 2016 Oct; 73(4):152-157. PubMed ID: 27922430 [TBL] [Abstract][Full Text] [Related]
12. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells. Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333 [TBL] [Abstract][Full Text] [Related]
13. Upregulated Expression of Serum Exosomal microRNAs as Diagnostic Biomarkers of Lung Adenocarcinoma. Feng M; Zhao J; Wang L; Liu J Ann Clin Lab Sci; 2018 Nov; 48(6):712-718. PubMed ID: 30610040 [TBL] [Abstract][Full Text] [Related]
14. Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma. Nakamura S; Sadakari Y; Ohtsuka T; Okayama T; Nakashima Y; Gotoh Y; Saeki K; Mori Y; Nakata K; Miyasaka Y; Onishi H; Oda Y; Goggins M; Nakamura M Ann Surg Oncol; 2019 Jul; 26(7):2104-2111. PubMed ID: 30820789 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer. Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108 [TBL] [Abstract][Full Text] [Related]
16. Expression profile of serum-related exosomal miRNAs from parathyroid tumor. Wang J; Wang Q; Zhao T; Liu X; Bai G; Xin Y; Shen H; Wei B Endocrine; 2021 Apr; 72(1):239-248. PubMed ID: 33161496 [TBL] [Abstract][Full Text] [Related]
17. Usefulness of exosome-encapsulated microRNA-451a as a minimally invasive biomarker for prediction of recurrence and prognosis in pancreatic ductal adenocarcinoma. Takahasi K; Iinuma H; Wada K; Minezaki S; Kawamura S; Kainuma M; Ikeda Y; Shibuya M; Miura F; Sano K J Hepatobiliary Pancreat Sci; 2018 Feb; 25(2):155-161. PubMed ID: 29130611 [TBL] [Abstract][Full Text] [Related]
18. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis. Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985 [TBL] [Abstract][Full Text] [Related]
19. Panel of serum miRNAs as potential non-invasive biomarkers for pancreatic ductal adenocarcinoma. Khan IA; Rashid S; Singh N; Rashid S; Singh V; Gunjan D; Das P; Dash NR; Pandey RM; Chauhan SS; Gupta S; Saraya A Sci Rep; 2021 Feb; 11(1):2824. PubMed ID: 33531550 [TBL] [Abstract][Full Text] [Related]
20. Identification of serum exosomal miR-148a as a novel prognostic biomarker for breast cancer. Li D; Wang J; Ma LJ; Yang HB; Jing JF; Jia MM; Zhang XJ; Guo F; Gao JN Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7303-7309. PubMed ID: 32706068 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]